These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 20055141)

  • 1. Preparation and evaluation of colon targeted drug delivery systems for albendazole using kneading, extrusion and compaction technology.
    Emeje M; Nwabunike P; Isimi Y; Kunle O; Ofoefule S
    Yao Xue Xue Bao; 2009 Oct; 44(10):1152-8. PubMed ID: 20055141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
    Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
    PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guar gum as a carrier for colon specific delivery; influence of metronidazole and tinidazole on in vitro release of albendazole from guar gum matrix tablets.
    Krishnaiah YS; Seetha Devi A; Nageswara Rao L; Bhaskar Reddy PR; Karthikeyan RS; Satyanarayana V
    J Pharm Pharm Sci; 2001; 4(3):235-43. PubMed ID: 11737989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix.
    Emeje MO; Kunle OO; Ofoefule SI
    Acta Pharm; 2006 Sep; 56(3):325-35. PubMed ID: 19831281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and in-vitro evaluation of dextrin matrix tablet of Ibuprofen for colon specific drug delivery.
    Salunkhe KS; Kulkarni MV
    Pak J Pharm Sci; 2008 Jan; 21(1):17-20. PubMed ID: 18166513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Carbopol 71G-NF on the release of dextromethorphan hydrobromide from extended-release matrix tablets.
    Fayed MH; Mahrous GM; Ibrahim MA; Sakr A
    Pharm Dev Technol; 2013; 18(5):971-81. PubMed ID: 21639691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyophilized mucoadhesive-dendrimer enclosed matrix tablet for extended oral delivery of albendazole.
    Mansuri S; Kesharwani P; Tekade RK; Jain NK
    Eur J Pharm Biopharm; 2016 May; 102():202-13. PubMed ID: 26563727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucoadhesive platforms for targeted delivery to the colon.
    Varum FJ; Veiga F; Sousa JS; Basit AW
    Int J Pharm; 2011 Nov; 420(1):11-9. PubMed ID: 21856393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin.
    Asghar LF; Chandran S
    Pharmazie; 2008 Oct; 63(10):736-42. PubMed ID: 18972836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, development and optimization of oral colon targeted drug delivery system of azathioprine using biodegradable polymers.
    Nath B; Nath LK
    Pharm Dev Technol; 2013; 18(5):1131-9. PubMed ID: 23167303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
    Grund J; Koerber M; Walther M; Bodmeier R
    Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of acryclic and metacrylic acid derivatives as sustained release matrices for theophylline hydrate tablets.
    Ofoefule SI; Chukwu A
    Boll Chim Farm; 1999 Nov; 138(10):526-30. PubMed ID: 10765469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once daily, high-dose mesalazine controlled-release tablet for colonic delivery: optimization of formulation variables using Box-Behnken design.
    Elbary AA; Aboelwafa AA; Al Sharabi IM
    AAPS PharmSciTech; 2011 Dec; 12(4):1454-64. PubMed ID: 22038474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon.
    Nguyen C; Christensen JM; Ayres JW
    Pharm Dev Technol; 2012; 17(1):73-83. PubMed ID: 20923254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronotherapeutic drug delivery of Tamarind gum, Chitosan and Okra gum controlled release colon targeted directly compressed Propranolol HCl matrix tablets and in-vitro evaluation.
    Newton AM; Indana VL; Kumar J
    Int J Biol Macromol; 2015 Aug; 79():290-9. PubMed ID: 25936283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
    Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
    Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of matrices of Eudragit with polycarbophil and carbopol for colon-specific delivery.
    Asghar LF; Chandran S
    J Drug Target; 2008 Dec; 16(10):741-57. PubMed ID: 19005938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
    Khan MZ; Prebeg Z; Kurjaković N
    J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.